Home LiteratureArticle Details
PMID: 1249521 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Subversion of host defense mechanisms by murine tumors. II. Counter-influence of concomitant antitumor immunity.

The Journal of experimental medicine ·Vol. 143 ·No. 3 ·1976-03-01 ·Pages 574-84

North RJ, Kirstein DP, Tuttle RL

Abstract

Subcutaneous injection of murine tumor cells first resulted in a state of severely suppressed macrophage-mediated antibacterial resistance and then in a contrasting state of greatly enhanced antibacterial resistance. Whereas, the state of suppressed antibacterial resistance corresponded to a state of suppressed resistance to a tumor cell challenge, the generation of enhanced antibacterial resistance corresponded to the acquisition of concomitant antitumor immunity. It was suggested on the basis of this evidence that changes in the level of macrophage-mediated antibacterial resistance that occur during growth of the primary tumor reflected changes in the level of the host's resistance to the tumor itself. It was further suggested that the coincidental suppression of antibacterial and antitumor resistance that occurs during the initial stages of growth of the primary tumor represents the operation of a mechanism that enables the tumor to avoid destruction by macrophages. The results support the view that macrophages play an important role in native and acquired resistance to malignant tumors.

MeSH Terms
Animals Antigens, Bacterial Antigens, Neoplasm Female Immunity, Cellular Immunosuppression Therapy Listeriosis/immunology Lymphoma/immunology Macrophages/immunology Male Mammary Neoplasms, Experimental/immunology Mice Neoplasm Transplantation Neoplasms, Experimental/immunology Sarcoma, Experimental/immunology Time Factors Transplantation, Homologous
Chemicals
Antigens, Bacterial Antigens, Neoplasm
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
North R J
Kirstein D P
Tuttle R L
References (8)
8 references, click to expand
  1. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Int J Cancer. 1975 Mar 15;15(3):438-50 PMID: 1079792
  2. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
    Cancer Res. 1975 Jan;35(1):30-6 PMID: 1089042
  3. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
    J Natl Cancer Inst. 1975 Mar;54(3):709-20 PMID: 1091741
  4. The reticuloendothelial system and the neoplastic process.
    Ann N Y Acad Sci. 1960 Jun 21;88:264-80 PMID: 13730686
  5. Mechanisms by which activated normal macrophages destroy syngeneic rat tumour cells in vitro. Cytokinetics, non-involvement of T lymphocytes, and effect of metabolic inhibitors.
    Immunology. 1974 Aug;27(2):285-98 PMID: 4370655
  6. In vitro nonimmunologic destruction of cells with abnormal growth characteristics by adjuvant activated macrophages.
    Proc Soc Exp Biol Med. 1972 Mar;139(3):1049-52 PMID: 5023754
  7. Reticulo-endothelial activity in humans with cancer.
    Br J Surg. 1970 Oct;57(10):748-52 PMID: 5476753
  8. Delayed lethal response to Candida albicans infection in mice bearing the Lewis lung carcinoma.
    J Natl Cancer Inst. 1975 Sep;55(3):731-3 PMID: 1159852
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1976-03-01
Pages
574-84
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2190144
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]